PATENT CLAIM ANALYSIS

Application Number: 15939604
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "019600"]

Abstract:
Provided are peptides, compositions comprising the peptides, and methods of using the peptide compositions for inhibition of growth of cancer cells. The peptides comprise a sequence of ARX 1 X 2 X 3 X 4 , and inhibit or disrupt the formation of MLL1 and SET1 complexes.

Claim (Index 2):
The peptide of  claim 1 , wherein ARX 1 X 2 X 3 X 4  (SEQ ID NO:1) has the following sequence: ARTEVY (SEQ ID NO:8) or ARTEPY (SEQ ID NO:9).

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.45714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12509874', '13415474', '15185299', '13160086', '13569583']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.756659106080941
- 35 USC 102 Novelty (BERT): 0.5715843123779808
- Combined Prediction Score: 0.7381516267106449
- Mean Citation Score: 350.393684
- Max Citation Score: 482.3067
- Similarity Product: 329.1088952401757

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test